Financials
Financial year 2025
Revenue
€ 385.9 million
▲ 7% vs 2024
Profit
Caution€ -3.1 million
▼ 134% vs 2024
Debts
Normal€ 244.4 million
▼ 6% vs 2024
NIPRO MEDICAL EUROPE from Mechelen, company number BE0444276727, closed financial year 2025 with a result of € -3.1 million after tax. For that financial year NIPRO MEDICAL EUROPE recorded revenue of € 385.9 million and equity of € 78.2 million. Compared with financial year 2024, the result moved from € 8.9 million to € -3.1 million. The company made a loss. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on June 15, 2026.
What happened at NIPRO MEDICAL EUROPE?
What happened at NIPRO MEDICAL EUROPE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Sensus Strategies stepped down as director. NBB
- Goichi MIYAZUMI stepped down as director. NBB
- New annual accounts for financial year 2025: loss of € 3.1 million (▼ 134% vs 2024). Source: NBB ↗
- Sensus Strategies became a director. NBB
- Goichi MIYAZUMI became a director. NBB
- New establishment in Mechelen. KBO
- Start of the company according to the CBE. KBO
In short
From € 6.7 million loss in 2021 to € 3.1 million loss in 2025.
Paid € 15.2 million in corporate taxes since 2021.
Best year ever: 2023, with € 11.6 million profit.
Pays suppliers within 158 days on average.
A new publication or filing at NIPRO MEDICAL EUROPE? We notify you, reason included.
Follow NIPRO MEDICAL EUROPENeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
The shares are held by Nipro Europe Group Companies NV (100%). It owns 100% of Nipro Medical Cameroon SARL, 100% of Nipro Medical Kenya Limited , 100% of Nipro Diagnostics Germany GmbH , 100% of Nipro Medical South Africa (PTY) LT , 100% of Nipro Medical Italy SRL and 100% of Nipro Senegal SUARL itself.
Directors
According to the 2025 annual accounts
since 2025 · until 2030
since 2024 · until 2030
Shareholders
Participations
Nipro Medical Cameroon SARL
100%
Nipro Medical Kenya Limited
100%
Nipro Diagnostics Germany GmbH
100%
Nipro Medical South Africa (PTY) LT
100%
Nipro Medical Italy SRL
100%
Nipro Senegal SUARL
100%
Nipro Medical Poland Sp. z o.o.
100%
OOO Nipro Medical
100%
Nipro Medical Spain, S.L.U
100%
Nipro MIC Technical Services GmbH
100%
URC SOUTH AFRICA (PTY) LTD
100%
Nipro Renal Solutions Spain, S.L.
100%
Nipro Pure Water GmbH
100%
Nipro Médical France
100%
Nipro Medical Morocco SARLAU
100%
Nipro Nordics AB
100%
Nipro Medical UK LTD
100%
Nipro Medical Ivory Coast
100%
Nipro Medical DOO Beograd
100%
NIPRO MEDIKAL SAG. HIZ. TIC. LTD. S
100%
Nipro Medical Germany GmbH
100%
Nipro Medical Austria GmbH
100%
Nipro Diagnostics UK Limited
100%
MTN Neubrandenburg GmbH
100%
Nipro Medical Nigeria
100%
Establishments
Establishment units
Physical locations of this company
Blokhuisstraat 42
2800 Mechelen
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 4 companies are registered at this address.
Details
- Company number
- 0444.276.727
- VAT number
- BE 0444.276.727
- Registered office
- Blokhuisstraat 42, 2800 Mechelen
- Names & denominations
- NIPRO MEDICAL EUROPE
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 27 May 1991
- Peppol
- Active · Active since 11 Dec 2025
- Activities · NACE
Groothandel in farmaceutische producten
Groothandel in farmaceutische en medische artikelen